Ashraf Amanullah
Chief Tech/Sci/R&D Officer bei INHIBRX, INC.
Profil
Ashraf Amanullah is currently the Chief Technical Operations Officer & Executive VP at Inhibrx, Inc. Prior to this, he held positions as the Director-Process Development at Genentech, Inc. from 2006 to 2011, Senior Director at Gilead Sciences, Inc. from 2011 to 2015, and Senior VP-Biologics Development & Manufacturing at aTyr Pharma, Inc. in 2018.
He obtained his undergraduate degree from the University of Birmingham and his doctorate degree from The University of Sheffield.
Aktive Positionen von Ashraf Amanullah
| Unternehmen | Position | Beginn |
|---|---|---|
| INHIBRX, INC. | Chief Tech/Sci/R&D Officer | 01.08.2018 |
Ehemalige bekannte Positionen von Ashraf Amanullah
| Unternehmen | Position | Ende |
|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01.07.2018 |
| GILEAD SCIENCES, INC. | Director/Board Member | 01.08.2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.08.2011 |
Ausbildung von Ashraf Amanullah
| University of Birmingham | Undergraduate Degree |
| The University of Sheffield | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ATYR PHARMA, INC. | Health Technology |
| INHIBRX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
